openPR Logo
Press release

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: HSDEF, OTC: HBORF)

10-27-2020 06:04 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on November 9, 2020 in the lawsuit for certain investors in Harborside Inc. (OTC: HSDEF, OTC: HBORF).

A Deadline is coming up on November 9, 2020 in the lawsuit for certain investors in Harborside Inc. (OTC: HSDEF, OTC: HBORF).

The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).

Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of Oregon the plaintiff alleges on behalf of purchasers of Harborside Inc. (OTC: HSDEF, OTC: HBORF) common shares between July 2, 2019 and August 12, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between July 2, 2019 and August 12, 2020, the defendants made false and/or misleading statements and/or failed to disclose that Harborside had undisclosed material weaknesses and insufficient financial controls, that Harborside’s previously issued financial statements were false and unreliable, that Harborside’s earlier reported financial statements would need restatement, that as a result of the foregoing and subsequent reporting delays, Harborside’s Canadian stock trading would be suspended, that Harborside downplayed the negative impacts of errors and delays regarding its financial statements, and that as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Those who purchased shares of Harborside Inc. (OTC: HSDEF) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: HSDEF, OTC: HBORF) here

News-ID: 2173700 • Views: 445

More Releases from Shareholders Foundation

Investors who lost money with shares of Planet Fitness, Inc. (NYSE: PLNT) should …
An investigation was announced for investors of Planet Fitness, Inc. (NYSE: PLNT) shares over potential securities laws violations by Planet Fitness, Inc. Investors who purchased shares of Planet Fitness, Inc. (NYSE: PLNT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Planet Fitness, Inc. (NYSE: PLNT)
Deadline on February 14th coming up in Lawsuit for Investors in Sunlight Financi …
A deadline is coming up on February 14, 2023 in the lawsuit filed for certain investors of Sunlight Financial Holdings Inc. (NYSE: SUNL) over alleged securities laws violations by Sunlight Financial Holdings Inc. f/k/a Spartan Acquisition Corp. II. Investors who purchased shares of Sunlight Financial Holdings Inc. (NYSE: SUNL) have certain options and there are strict and short deadlines running. Deadline: February 14, 2023. NYSE: SUNL stockholders should contact the Shareholders
Investigation announced for Investors in shares of Avery Dennison Corporation (N …
An investigation was announced over potential securities laws violations by Avery Dennison Corporation in connection with certain financial statements. Investors who purchased shares of Avery Dennison Corporation (NYSE: AVY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Avery Dennison Corporation regarding its business, its prospects and its operations were
Deadline on February 10th coming up in Lawsuit for Investors in Twist Bioscience …
A deadline is coming up on February 10, 2023 in the lawsuit filed for certain investors of Twist Bioscience Corporation (NASDAQ: TWST) over alleged securities laws violations by Twist Bioscience Corporation. Investors who purchased shares of Twist Bioscience Corporation (NASDAQ: TWST) have certain options and there are strict and short deadlines running. Deadline: February 10, 2023. NASDAQ: TWST stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for OTC:

Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current